Audemars Piguet News
-
Watch industry consolidation is crimping creativity and making it harder for independent watchmakers to compete, said Pascal Ravessoud, marketing and development director of the Fondation de la Haute Horlogerie.
-
Here’s a surefire way to spend some time with Scarlett Johansson : An Audemars Piguet watch signed by the film and stage star is one of 27 luxury timepieces slated for the auction block tonight. The Johansson model, with her signature engraved on the back, will probably cost you $32,000 and change.
-
Audemars Piguet had record sales of more than 550 million Swiss francs ($590 million) in 2011 as it sold more than 30,000 watches, Le Temps said, citing Chief Executive Officer Philippe Merk.
-
Europe’s crisis is imposing fiscal discipline on working households, spendthrift governments -- and the occasional billionaire.
-
Michael Schumacher ’s record seven Formula One championships lured Swiss luxury retail brands when he made a comeback last year. They’re still waiting for him to get his form back.
-
Switzerland’s Vallee de Joux has 6,000 people living in its 10 villages. Luxury watchmakers based there, including Audemars Piguet and Jaeger-LeCoultre, need at least that many workers, leaving them dependent on French to top up the ranks of horologers.
-
Switzerland’s Vallee de Joux has 6,000 people living in its 10 villages. Luxury watchmakers based there, including Audemars Piguet and Jaeger-LeCoultre, need at least that many workers, leaving them dependent on French to top up the ranks of horologers.
-
Wang Hui says she doesn’t care about the money. She wants to know why her husband, Zheng Hangzheng, never made it home from a business trip on July 23.
-
Switzerland’s exports of watches may rise to a record in 2011 as demand for luxury timepieces continues to recover, said Jean-Daniel Pasche , head of the Federation of the Swiss Watch Industry.
-
Cubist Pharmaceuticals Inc., a maker of antibiotic medicines, sued Hospira Inc. for patent infringement over plans to market a generic version of Cubicin, a drug used to combat the MRSA flesh-eating bacterium.
|
|
Most Popular on Bloomberg
|
| |
Rate this Page